Bajaj HealthCare Limited (BAJAJHCARE.NS)
INR 584.25
(2.63%)
INR 584.25
(2.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -837.93 Million INR | -294.76% |
| 2022 | 430.24 Million INR | -39.73% |
| 2021 | 713.85 Million INR | -14.11% |
| 2020 | 831.08 Million INR | 229.32% |
| 2019 | 252.36 Million INR | 54.73% |
| 2018 | 163.1 Million INR | 7.4% |
| 2017 | 151.86 Million INR | 94.08% |
| 2016 | 78.24 Million INR | -4.58% |
| 2015 | 82 Million INR | 9.12% |
| 2014 | 75.14 Million INR | 281.19% |
| 2013 | 19.71 Million INR | 286.72% |
| 2012 | -10.55 Million INR | -262.38% |
| 2011 | 6.5 Million INR | -85.46% |
| 2010 | 44.73 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 71.31 Million INR | 123.83% |
| 2023 Q1 | -482.11 Million INR | -1442.08% |
| 2023 Q2 | -34.6 Million INR | 92.82% |
| 2023 Q3 | -21.96 Million INR | 36.54% |
| 2023 Q4 | -299.24 Million INR | -1262.49% |
| 2023 FY | -837.93 Million INR | -294.76% |
| 2022 Q4 | 35.92 Million INR | -67.5% |
| 2022 Q1 | 120.18 Million INR | -31.21% |
| 2022 Q2 | 163.58 Million INR | 36.11% |
| 2022 Q3 | 110.54 Million INR | -32.42% |
| 2022 FY | 430.24 Million INR | -39.73% |
| 2021 FY | 713.85 Million INR | -14.11% |
| 2021 Q2 | 172.51 Million INR | -10.23% |
| 2021 Q4 | 174.72 Million INR | 0.15% |
| 2021 Q3 | 174.45 Million INR | 1.12% |
| 2021 Q1 | 192.17 Million INR | -9.68% |
| 2020 Q2 | 201.16 Million INR | 31.55% |
| 2020 FY | 831.08 Million INR | 229.32% |
| 2020 Q1 | 152.91 Million INR | 59.28% |
| 2020 Q4 | 212.77 Million INR | -19.47% |
| 2020 Q3 | 264.22 Million INR | 31.35% |
| 2019 Q1 | 32.41 Million INR | -35.53% |
| 2019 Q2 | 32.77 Million INR | 1.1% |
| 2019 FY | 252.36 Million INR | 54.73% |
| 2019 Q3 | 63.8 Million INR | 94.67% |
| 2019 Q4 | 96 Million INR | 50.48% |
| 2018 Q1 | 62.52 Million INR | 30.72% |
| 2018 Q4 | 50.28 Million INR | -0.0% |
| 2018 Q3 | 50.28 Million INR | 60.84% |
| 2018 Q2 | 31.26 Million INR | -50.0% |
| 2018 FY | 163.1 Million INR | 7.4% |
| 2017 Q1 | 28.09 Million INR | 27.96% |
| 2017 Q3 | 47.83 Million INR | 70.23% |
| 2017 Q2 | 28.09 Million INR | 0.0% |
| 2017 FY | 151.86 Million INR | 94.08% |
| 2017 Q4 | 47.83 Million INR | 0.0% |
| 2016 FY | 78.24 Million INR | -4.58% |
| 2016 Q4 | 21.95 Million INR | 0.0% |
| 2016 Q3 | 21.95 Million INR | 27.92% |
| 2016 Q2 | 17.16 Million INR | 0.0% |
| 2016 Q1 | 17.16 Million INR | 45.9% |
| 2015 Q1 | 29.23 Million INR | 0.0% |
| 2015 FY | 82 Million INR | 9.12% |
| 2015 Q3 | 6.07 Million INR | -79.23% |
| 2015 Q4 | 11.76 Million INR | 93.8% |
| 2015 Q2 | 29.23 Million INR | 0.0% |
| 2014 FY | 75.14 Million INR | 281.19% |
| 2013 FY | 19.71 Million INR | 286.72% |
| 2012 FY | -10.55 Million INR | -262.38% |
| 2011 FY | 6.5 Million INR | -85.46% |
| 2010 FY | 44.73 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aarti Drugs Limited | 1.71 Billion INR | 148.882% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 138.632% |
| Albert David Limited | 754.2 Million INR | 211.102% |
| Alembic Limited | 2.68 Billion INR | 131.194% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | 11915.158% |
| Hester Biosciences Limited | 188.89 Million INR | 543.608% |
| Hikal Limited | 696 Million INR | 220.392% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 119.905% |
| Ind-Swift Limited | 142.31 Million INR | 688.794% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 162.332% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | 673.87% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | 189.806% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | -823.676% |
| Medico Remedies Limited | 82.9 Million INR | 1110.663% |
| Morepen Laboratories Limited | 961.59 Million INR | 187.139% |
| Procter & Gamble Health Limited | 2 Billion INR | 141.692% |
| RPG Life Sciences Limited | 876.6 Million INR | 195.589% |
| Sigachi Industries Limited | 571.8 Million INR | 246.542% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 100.875% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 127.905% |
| Themis Medicare Limited | 435.23 Million INR | 292.522% |
| Unichem Laboratories Limited | -704.74 Million INR | -18.899% |
| Vaishali Pharma Limited | 7.18 Million INR | 11755.738% |
| Venus Remedies Limited | 284.9 Million INR | 394.106% |
| Windlas Biotech Limited | 581.87 Million INR | 244.007% |
| ZIM Laboratories Limited | 172.46 Million INR | 585.858% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 113.607% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | 1240.368% |
| FDC Limited | 3.05 Billion INR | 127.453% |
| Gufic Biosciences Limited | 861.35 Million INR | 197.28% |
| Jubilant Pharmova Limited | 771 Million INR | 208.681% |
| Nectar Lifesciences Limited | 49.95 Million INR | 1777.54% |
| Orchid Pharma Limited | 921.66 Million INR | 190.915% |
| Alkem Laboratories Limited | 17.95 Billion INR | 104.666% |
| Brooks Laboratories Limited | -195.91 Million INR | -327.693% |
| Eris Lifesciences Limited | 3.91 Billion INR | 121.377% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 117.795% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 85.232% |
| Innova Captab Limited | 943.45 Million INR | 188.816% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 473.027% |
| Wanbury Limited | 559.56 Million INR | 249.747% |
| Lupin Limited | 19.14 Billion INR | 104.377% |
| Sakar Healthcare Limited | 116.7 Million INR | 817.966% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 102.641% |
| Divi's Laboratories Limited | 16 Billion INR | 105.237% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 151.881% |
| Mankind Pharma Limited | 19.12 Billion INR | 104.38% |
| Sequent Scientific Limited | -358.69 Million INR | -133.609% |
| Laurus Labs Limited | 1.6 Billion INR | 152.191% |
| Neuland Laboratories Limited | 3 Billion INR | 127.924% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 115.163% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 94.42% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 102.171% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 286.32% |
| Wockhardt Limited | -4.63 Billion INR | 81.902% |
| Bal Pharma Limited | 73.92 Million INR | 1233.534% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 101.505% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 211.052% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | 677.844% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 118.332% |
| Shilpa Medicare Limited | 318.74 Million INR | 362.887% |
| Valiant Laboratories Limited | 3.19 Million INR | 26318.116% |
| Ajanta Pharma Limited | 8.16 Billion INR | 110.267% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | 1889.049% |
| Granules India Limited | 4.05 Billion INR | 120.674% |
| Medicamen Biotech Limited | 109.31 Million INR | 866.564% |
| Ipca Laboratories Limited | 5.47 Billion INR | 115.309% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 431.012% |
| Piramal Enterprises Limited | -16.83 Billion INR | 95.023% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 105.059% |
| NATCO Pharma Limited | 13.88 Billion INR | 106.036% |
| Suven Life Sciences Limited | -1.05 Billion INR | 20.255% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | -324.733% |
| Strides Pharma Science Limited | -706.14 Million INR | -18.664% |
| Indoco Remedies Limited | 984.6 Million INR | 185.104% |
| Alpa Laboratories Limited | 167.76 Million INR | 599.467% |
| Lasa Supergenerics Limited | -217.3 Million INR | -285.6% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 78.36% |